DK175349B1 - Farmaceutisk tablet indeholdende cefuroxim-axetil - Google Patents

Farmaceutisk tablet indeholdende cefuroxim-axetil Download PDF

Info

Publication number
DK175349B1
DK175349B1 DK198604624A DK462486A DK175349B1 DK 175349 B1 DK175349 B1 DK 175349B1 DK 198604624 A DK198604624 A DK 198604624A DK 462486 A DK462486 A DK 462486A DK 175349 B1 DK175349 B1 DK 175349B1
Authority
DK
Denmark
Prior art keywords
tablet
film coating
film
breaking
seconds
Prior art date
Application number
DK198604624A
Other languages
Danish (da)
English (en)
Other versions
DK462486A (da
DK462486D0 (da
Inventor
Jamshed Anwar
David Samuel Deutsch
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10585921&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK175349(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DK462486D0 publication Critical patent/DK462486D0/da
Publication of DK462486A publication Critical patent/DK462486A/da
Application granted granted Critical
Publication of DK175349B1 publication Critical patent/DK175349B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
DK198604624A 1985-09-30 1986-09-29 Farmaceutisk tablet indeholdende cefuroxim-axetil DK175349B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858524001A GB8524001D0 (en) 1985-09-30 1985-09-30 Pharmaceutical composition
GB8524001 1985-09-30

Publications (3)

Publication Number Publication Date
DK462486D0 DK462486D0 (da) 1986-09-29
DK462486A DK462486A (da) 1987-03-31
DK175349B1 true DK175349B1 (da) 2004-09-06

Family

ID=10585921

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198604624A DK175349B1 (da) 1985-09-30 1986-09-29 Farmaceutisk tablet indeholdende cefuroxim-axetil

Country Status (29)

Country Link
US (1) US4897270A (de)
EP (1) EP0223365B1 (de)
JP (1) JP2661662B2 (de)
KR (1) KR940000233B1 (de)
AT (1) AT393081B (de)
AU (1) AU594082B2 (de)
BE (1) BE905518A (de)
CA (1) CA1282331C (de)
CH (1) CH672736A5 (de)
CY (1) CY1563A (de)
DE (2) DE3677710D1 (de)
DK (1) DK175349B1 (de)
ES (1) ES2002382A6 (de)
FR (1) FR2591597B1 (de)
GB (2) GB8524001D0 (de)
GR (1) GR862464B (de)
HK (1) HK84990A (de)
IE (1) IE59089B1 (de)
IL (1) IL80165A (de)
IT (1) IT1196644B (de)
LU (1) LU86613A1 (de)
NL (1) NL8602466A (de)
NO (1) NO173636C (de)
NZ (1) NZ217720A (de)
PH (1) PH25702A (de)
PT (1) PT83459B (de)
SA (1) SA91120189B1 (de)
SE (1) SE8604114L (de)
ZA (1) ZA867318B (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
US4880636A (en) * 1988-05-13 1989-11-14 Franz Robert M Film coated tablet of ranitidine HCl
AT393955B (de) * 1990-03-30 1992-01-10 Martin Dr Leixnering Einrichtung zur nachbehandlung frischer beugesehnenverletzungen
FR2666506A1 (fr) * 1990-09-07 1992-03-13 Pf Medicament Comprime a liberation prolongee a base de 5-mononitrate d'isosorbide et son procede de preparation.
GB2256587A (en) * 1991-06-11 1992-12-16 American Cyanamid Co Acetazolamide in sustained release form
US5234696A (en) * 1991-12-27 1993-08-10 Abbott Laboratories Method of producing tablets, tablets produced thereby, and method of treatment using same
HRP970493A2 (en) * 1996-09-23 1998-08-31 Wienman E. Phlips Oral delayed immediate release medical formulation and method for preparing the same
CO4920215A1 (es) * 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones
US20020022056A1 (en) 1997-02-14 2002-02-21 Burkhard Schlutermann Oxacarbazepine film-coated tablets
CA2209868C (en) * 1997-08-15 2001-08-14 Bernard Charles Sherman Pharmaceutical compositions comprising cefuroxime axetil
IN186539B (de) * 1997-09-29 2001-09-29 Ranbaxy Lab Ltd
WO1999044614A1 (en) * 1998-03-03 1999-09-10 Daewoong Pharmaceutical Co., Ltd. Pharmaceutical composition containing cefuroxime axetil stable for moisture absorption
CA2239331C (en) * 1998-05-29 1999-11-30 Bernard Charles Sherman Pharmaceutical tablets comprising cefuroxime axetil
US6531152B1 (en) 1998-09-30 2003-03-11 Dexcel Pharma Technologies Ltd. Immediate release gastrointestinal drug delivery system
AT413647B (de) * 1998-11-26 2006-04-15 Sandoz Ag Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten
US6632451B2 (en) 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
IN191239B (de) 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
CZ20014379A3 (cs) * 1999-06-11 2002-08-14 Ranbaxy Laboratories Limited Kompozice k maskování chuti a způsob její přípravy
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
CA2280925A1 (en) 1999-07-29 2001-01-29 Bernard Charles Sherman Stabilized cefuroxime axetil
KR100342943B1 (ko) * 1999-08-04 2002-07-02 민경윤 비결정질 세푸록심 악세틸 고형분산체, 이의 제조 방법 및 이를 포함하는 경구투여용 조성물
JP2001122791A (ja) * 1999-10-20 2001-05-08 Boehringer Ingelheim Internatl Gmbh 下肢の慢性静脈不全の軽減および予防のための赤色ブドウ樹葉の水性抽出物よりなる食事補強剤
AT500063A1 (de) * 1999-11-23 2005-10-15 Sandoz Ag Beschichtete tablettenkerne
EP1414417A1 (de) * 2000-12-01 2004-05-06 Abdul Rehman Wockhardt Research Centre Khan Pharmazeutische formulierung
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
HRP20020923A2 (en) * 2001-11-23 2003-10-31 Glaxo Group Ltd Pharmaceutical composition
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
KR100523082B1 (ko) * 2002-09-11 2005-10-20 (주)다산메디켐 쓴 맛이 은폐된 세푸록심악세틸 제제의 제약조성물 및 그의 제조방법
US20040151769A1 (en) * 2002-12-31 2004-08-05 Boehringer Ingelheim International Gmbh Film coated tablet containing an extract of red vine leaves
ES2346649T3 (es) * 2002-12-31 2010-10-19 Boehringer Ingelheim International Gmbh Comprimido recubierto con una pelicula que comprende un extracto de hojas de parra rojas.
US20050079213A1 (en) * 2003-06-06 2005-04-14 Unilab Pharmatech Ltd Pharmaceutical compositions
KR100552567B1 (ko) * 2003-08-23 2006-02-15 한국유나이티드제약 주식회사 수분 흡수에 안정하고 빠르게 붕해되는 세푸록심 악세틸을포함하는 정제의 조성물 및 제조 방법
US20050084540A1 (en) * 2003-10-17 2005-04-21 Indranil Nandi Taste masking antibiotic composition
EP1550450A1 (de) * 2003-12-29 2005-07-06 Boehringer Ingelheim International GmbH Behandlung von chronischer venöser Insuffizienz mit einem Extrakt aus Blättern von roten Weinreben und einem Blutumlauf verbesserndes Mittel
US20090175952A1 (en) * 2004-01-09 2009-07-09 Jong Soo Woo Cefuroxime axetil granule and process for the preparation thereof
GB0403628D0 (en) * 2004-02-18 2004-03-24 Arrow Group Ltd Compression-coated tablets and the manufacture thereof
CA2551787C (en) * 2004-02-19 2014-04-08 Boehringer Ingelheim International Gmbh Composition for the treatment of chronic venous insufficiencies comprising an extract of red vine leaves and an anti-inflammatory agent
EP1737433B1 (de) * 2004-04-12 2007-11-14 Pfizer Products Incorporated Arzneiimittel mit verdecktem geschmack in aufbrechenden multipartikeln
US20060099253A1 (en) * 2004-10-20 2006-05-11 Wyeth Antibiotic product formulation
US20070009573A1 (en) * 2005-07-07 2007-01-11 L N K International Method of forming immediate release dosage form
US10357462B2 (en) * 2006-11-30 2019-07-23 Ben Research, Inc. Multiparticulates of spray-coated drug and polymer on a meltable core
US11116728B2 (en) 2006-11-30 2021-09-14 Bend Research, Inc. Multiparticulates of spray-coated drug and polymer on a meltable core
US8529914B2 (en) * 2010-06-28 2013-09-10 Richard C. Fuisz Bioactive dose having containing a material for modulating pH of a bodily fluid to help or hinder absorption of a bioactive
BR112014020186A8 (pt) 2012-02-22 2017-07-11 Duchesnay Inc Formulação de doxilamina e piridoxina e/ou seus metabólitos ou sais
EP2833873A1 (de) * 2012-04-04 2015-02-11 Mahmut Bilgic Filmtablettenformulierungen mit cefuroxim-axetil und clavulansäure
ES2768651T3 (es) 2013-04-25 2020-06-23 Kyorin Seiyaku Kk Composición farmacéutica sólida
WO2014174847A1 (ja) 2013-04-25 2014-10-30 杏林製薬株式会社 固形医薬組成物
MX366760B (es) 2013-07-22 2019-07-23 Duchesnay Inc Composición para la gestión de las náuseas y los vómitos.
CA2965473A1 (en) 2014-10-23 2016-04-28 Kyorin-Pharmaceutical Co., Ltd. Solid pharmaceutical composition
DE202022100544U1 (de) 2022-01-31 2022-02-16 Ranjitsing Babasing Bayas Neue orale Streifen- oder Dünnfilmform von Diclofenac-Natrium

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3372015A (en) * 1963-11-15 1968-03-05 Pittsburgh Plate Glass Co Method of and apparatus for equalizing the cooling of a glass sheet supported on a bending mold
US3383236A (en) * 1964-04-17 1968-05-14 Merck & Co Inc Continuous pharmaceutical film coating process
FR1426194A (fr) * 1964-10-20 1966-01-28 Ile De France Nouvelle technique d'enrobage des comprimés
US3256111A (en) * 1964-12-04 1966-06-14 Abbott Lab Method for coating tablets
US3477864A (en) * 1965-05-07 1969-11-11 Sumitomo Chemical Co Process for coating pharmaceutical preparations with a hydroxy propyl methyl cellulose-sealing agent moisture-preventing film
US3539380A (en) * 1968-01-08 1970-11-10 Upjohn Co Methylcellulose and polyalkylene glycol coating of solid medicinal dosage forms
US3981984A (en) * 1968-04-01 1976-09-21 Colorcon Incorporated Color film coating of tablets and the like
DE2259646C2 (de) * 1972-12-06 1984-11-22 Hoechst Ag, 6230 Frankfurt Hochdosierte Tabletten von Cephalosporin-Derivaten sowie Verfahren zu ihrer Herstellung
US4140764A (en) * 1974-12-18 1979-02-20 Beecham Group Limited β-Lactamase inhibitors and process for their preparation
US4143129A (en) * 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets
CA1094545A (en) * 1976-02-16 1981-01-27 Michael Gregson Cephalosporin antibiotics
GB1571683A (en) * 1976-02-16 1980-07-16 Glaxo Operations Ltd Ester derivatives of cefuroxime
CA1093549A (en) * 1976-02-16 1981-01-13 Michael Gregson Cephalosporin antibiotics
JPS52151717A (en) * 1976-06-09 1977-12-16 Shionogi & Co Ltd Sugar coating on solid preparations
JPS55129224A (en) * 1979-03-27 1980-10-06 Toyo Jozo Co Ltd Fine granules having improved taste
FI75578C (fi) * 1979-07-25 1988-07-11 Ciba Geigy Ag Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider.
US4470980A (en) * 1980-03-07 1984-09-11 Interx Research Corp. Method of increasing oral absorption of β-lactam antibiotics
US4302440B1 (en) * 1980-07-31 1986-08-05 Easily-swallowed, powder-free and gastric-disintegrable aspirin tablet thinly-coated with hydroxypropyl methylcellulose and aqueous spray-coating preparation thereof
JPS5885813A (ja) * 1981-11-17 1983-05-23 Toyo Jozo Co Ltd 吸収性良好な製剤
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
DE3237575A1 (de) * 1982-10-09 1984-04-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale mopidamolformen
ATE67769T1 (de) * 1983-01-25 1991-10-15 Ciba Geigy Ag Neue peptidderivate.
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
GB8320520D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
GB8320521D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
GB8324152D0 (en) * 1983-09-09 1983-10-12 Glaxo Group Ltd Chemical process
EP0147780A3 (de) * 1984-01-03 1987-03-11 Merck & Co. Inc. Vorrichtung zur Freisetzung von Arzneistoffen
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics
JPS60169416A (ja) * 1984-02-14 1985-09-02 Taisho Pharmaceut Co Ltd 素錠の表面処理方法
US4616008A (en) * 1984-05-02 1986-10-07 Takeda Chemical Industries, Ltd. Antibacterial solid composition for oral administration
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.

Also Published As

Publication number Publication date
HK84990A (en) 1990-10-25
IE862564L (en) 1987-03-30
BE905518A (fr) 1987-03-30
FR2591597B1 (fr) 1989-06-02
DK462486A (da) 1987-03-31
US4897270A (en) 1990-01-30
KR870002832A (ko) 1987-04-13
NO863863D0 (no) 1986-09-29
AU594082B2 (en) 1990-03-01
ATA260986A (de) 1991-01-15
CA1282331C (en) 1991-04-02
FR2591597A1 (fr) 1987-06-19
KR940000233B1 (ko) 1994-01-12
NO173636B (no) 1993-10-04
SE8604114L (sv) 1987-03-31
GB2181052B (en) 1989-10-18
SA91120189B1 (ar) 2001-10-07
EP0223365B1 (de) 1991-02-27
AU6323286A (en) 1987-04-02
CY1563A (en) 1991-05-17
SE8604114D0 (sv) 1986-09-29
NL8602466A (nl) 1987-04-16
NZ217720A (en) 1988-07-28
ZA867318B (en) 1987-05-27
NO173636C (no) 1994-01-12
PH25702A (en) 1991-09-18
PT83459B (pt) 1989-05-12
DK462486D0 (da) 1986-09-29
IT1196644B (it) 1988-11-16
IL80165A0 (en) 1986-12-31
AT393081B (de) 1991-08-12
GB8623340D0 (en) 1986-11-05
EP0223365A3 (en) 1988-06-08
EP0223365A2 (de) 1987-05-27
IT8648492A0 (it) 1986-09-29
GB2181052A (en) 1987-04-15
GR862464B (en) 1987-02-02
DE3633292A1 (de) 1987-04-09
ES2002382A6 (es) 1988-08-01
CH672736A5 (de) 1989-12-29
PT83459A (en) 1986-10-01
IE59089B1 (en) 1994-01-12
DE3677710D1 (de) 1991-04-04
JPS62123118A (ja) 1987-06-04
NO863863L (no) 1987-03-31
LU86613A1 (fr) 1988-04-05
IL80165A (en) 1991-06-10
GB8524001D0 (en) 1985-11-06
JP2661662B2 (ja) 1997-10-08

Similar Documents

Publication Publication Date Title
DK175349B1 (da) Farmaceutisk tablet indeholdende cefuroxim-axetil
KR100359043B1 (ko) 수분차단필름피복조성물,방법,및피복제형
JP4704685B2 (ja) 徐放性製剤
KR100512515B1 (ko) 덱스트린을 기재로 한 필름 코팅물 및 필름 코팅 조성물
KR101783945B1 (ko) 향상된 수분차단 속방출형 필름의 코팅 시스템 및 이에 의하여 코팅된 기재
AU776662B2 (en) Coating of tablet cores
US6270798B2 (en) Lozenge for the modified releasing of active substances in the gastrointestinal tract
JPS6229515A (ja) 硬カプセル剤のフイルムコ−テイング方法
JP2005538105A (ja) 水不溶性ポリマーおよび水溶性の小孔形成物質からなる２層により被覆された固体剤形の製造方法
KR20010021921A (ko) 순백색 필름 코팅 및 이를 위한 필름 코팅 조성물
KR20010022439A (ko) 항궤양 활성 화합물을 포함하는 경구용 약제학적 제제 및이의 제조방법
JP2002515074A (ja) 防湿性フィルム被覆材組成物、方法および被覆成形物
US20090004284A1 (en) Controlled release tamsulosin hydrochloride formulation
KR930001277B1 (ko) 췌장 효소 제품의 제조방법
EP0418597A2 (de) Kohlensäureanhydraseinhibitoren enthaltende Arzneimittel mit gesteuerter Freisetzung aus kugelförmigen Granulatkörnern in oraler Kapseleinzeldosisform
CA3160862A1 (en) Dosage form for use in treating or preventing of a disease
KR100552567B1 (ko) 수분 흡수에 안정하고 빠르게 붕해되는 세푸록심 악세틸을포함하는 정제의 조성물 및 제조 방법
KR20030025903A (ko) 아크릴 장용 코팅 조성물
CN1232386A (zh) 弱酸药物的结肠运送
WO2023068289A1 (ja) 医薬組成物およびその製造方法
CN109568281B (zh) 一种柳氮磺胺吡啶片及其制备方法
JP3024496B2 (ja) 腸内有用細菌含有錠剤
JPH0466846B2 (de)
JP2006188472A (ja) 医薬用コーティング剤改質剤
JPH1081620A (ja) 無溶媒でコーティングされた固形製剤及びその後処理方法

Legal Events

Date Code Title Description
PUP Patent expired